Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 27, 2019
[Quality of operative treatment of pelvic fractures is not influenced by an additional abdominal injury : A monocentric registry study]Robert Bachmann, Michael Poppele, Patrick Ziegler, et al.
Breast Cancer Research and Treatment|March 23, 2006
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patientsErich F Solomayer, Sven Becker, Graziella Pergola-Becker, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 8, 2015
The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian CancerRobert Bachmann, Ralf Rothmund, Bernhard Krämer, et al.
International Journal of Surgery (London, England)|August 23, 2015
Metabolic alteration--Overcoming therapy resistance in gastric cancer via PGK-1 inhibition in a combined therapy with standard chemotherapeuticsCarl Christoph Schneider, Rami Archid, Nathania Fischer, et al.
World Journal of Emergency Surgery : WJES|January 29, 2020
Associated abdominal injuries do not influence quality of care in pelvic fractures-a multicenter cohort study from the German Pelvic RegistryMarkus A Küper, Robert Bachmann, Götz F Wenig, et al.
American Journal of Physiology. Cell Physiology|May 26, 2006
Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytesTobias Hermle, Ekaterina Shumilina, Philipp Attanasio, et al.
Trials|February 2, 2023
Prophylactic effect of retromuscular mesh placement during loop ileostomy closure on incisional hernia incidence-a multicentre randomised patient- and observer-blind trial (P.E.L.I.O.N trial)Sven Müller, Dirk Weyhe, Florian Herrle, et al.
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trialCihan Gani, Emmanouil Fokas, Bülent Polat, et al.
Pageof 3